Authors:
Theodoropoulou, S
Spanakos, G
Baxevanis, CN
Economou, M
Gritzapis, AD
Papamichail, MP
Stefanis, CN
Citation: S. Theodoropoulou et al., Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients, SCHIZOPHR R, 47(1), 2001, pp. 13-25
Authors:
Tsiatas, ML
Gritzapis, AD
Cacoullos, NT
Papadhimitriou, SI
Baxevanis, CN
Papamichail, M
Citation: Ml. Tsiatas et al., A novel culture environment for generating mature human dentritic cells from peripheral blood CD14(+) cells, ANTICANC R, 21(2A), 2001, pp. 1199-1206
Authors:
Voelter, W
Stoeva, S
Echner, H
Beck, A
Schutz, J
Lehmann, R
Haring, HU
Schleicher, E
Mullen, AM
Casserly, U
Troy, DJ
Tsitsilonis, OE
Lymberi, P
Baxevanis, CN
Papamichail, M
Citation: W. Voelter et al., Analytical tools for rapid, sensitive, quantitative identification of potential meat quality markers, J PRAK CH C, 342(2), 2000, pp. 179-191
Authors:
Voutsas, IF
Baxevanis, CN
Gritzapis, AD
Missitzis, I
Stathopoulos, GP
Archodakis, G
Banis, C
Voelter, W
Papamichail, M
Citation: If. Voutsas et al., Synergy between interleukin-2 and prothymosin alpha for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas, CANCER IMMU, 49(8), 2000, pp. 449-458
Authors:
Baxevanis, CN
Voutsas, IF
Tsitsilonis, OE
Gritzapis, AD
Sotiriadou, R
Papamichail, M
Citation: Cn. Baxevanis et al., Tumor-specific CD4(+) T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor, J IMMUNOL, 164(7), 2000, pp. 3902-3912
Authors:
Kosmas, EN
Michaelides, SA
Polychronaki, A
Roussou, T
Toukmatzi, S
Polychronopoulos, V
Baxevanis, CN
Citation: En. Kosmas et al., Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics, EUR RESP J, 13(1), 1999, pp. 53-58
Authors:
Baxevanis, CN
Spanakos, G
Voutsas, IF
Gritzapis, AD
Tsitsilonis, OE
Mamalaki, A
Papamichail, M
Citation: Cn. Baxevanis et al., Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin alpha, CANCER IMMU, 48(2-3), 1999, pp. 71-84